Skip to main content
 Events banner


Register for our Our Drug RepurposingMeeting

A fully interactive meeting with an excellent line-up of invited speakers to join those selected from your submitted abstracts

Janet Thornton (European Bioinformatics Institute, England) 

 Pankaj Agarwal (GSK, USA)

 Heather Mortiboys (University of Sheffield, England)

Eric Brown (McMaster University, Canada)

 Martin Zeidler (University of Sheffield, England)

 Rebecca Fairclough (AstraZeneca, England)

 Farhat Khanim (University of Birmingham, England)

 Darren Flower (Aston University, England)

 Sieu Tay (Quotient Sciences, England)

Bettina Schock (Queen's University Belfast, Northern Ireland)

18-19 November 2019
IET Birmingham: Austin Court
Abstract deadline: 18 September 2019.
Earlybird registration deadline: 18 September 2019.

Drug repurposing represents a promising approach to find new therapeutic uses for existing drugs. This two-day meeting will provide a platform to highlight some of the latest developments in the field of drug repurposing.
There is a need for more systematic and strategic approaches and resources, and this meeting wants to highlight and showcase such efforts besides recent drug repurposing studies.
The field of drug repurposing provides a natural opportunity to combine the strengths of the academic and industrial field. Therefore, we encourage scientists from both sectors, as well as clinicians, to attend this meeting and use it as a networking opportunity and an interdisciplinary forum for discussion.

Comments

Post a Comment

Popular posts from this blog

New research by a Nottingham academic linking the neurodegenerative disease Parkinson’s to changes in a protein in brain mitochondria is to receive support from a prestigious US funding agency. Dr Lisa Chakrabarti, at The University of Nottingham, will receive $75,000 for a one-year research project from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which is dedicated to finding a cure for Parkinson’s and funds promising research that could result in new treatments to slow, stop or reverse the progression of the disease. Dr Chakrabarti said: “We are trying to look at mitochondrial biology from a totally different perspective, which could have important implications for Parkinson’s and other neurodegenerative diseases. The funding from The Michael J. Fox Foundation will help us to confirm whether some of the protein changes we see in Parkinson’s are related to disease course.” http://exchange.nottingham.ac.uk/research/parkinsons-study-receives-fu...
Post a Comment
Read more

Some impressions from the expedition

 
Post a Comment
Read more

Katie and Jacob presented their work at the European Drosophila Research Conference in Alicante - September 25th-28th 2025

EDRC 2025 Alicante   Using a CaFe assay to assess mitochondrial function in olanzapine treated D.melanogaster.  Katherine Mortimer  'The EDRC 2025 brought together researchers from a diverse range of disciplines with a shared interest in using Drosophila melanogaster as a biological model. For that reason, I thoroughly enjoyed the poster session. I had lots of interesting conversations pertaining to all areas of my poster, from specific methodology to a general interest in mitochondria. I found myself chatting to people for the whole 2-hour session and walking away with lots of useful insights and connections. ' Quantum Sensing of Mitochondrial Physiology in Response to a Hypomagnetic Field. Jacob Reed 'It was great to be surrounded by researchers from around the world at the 28th EDRC, all sharing a passion for Drosophila. I especially enjoyed the talks on metabolism and mitochondria, which led to insightful conversations on mito-nuclear DNA mismatch. Presentin...
Post a Comment
Read more